A field-by-field walk through a certificate of analysis posts 61–90
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.
Post #60 and I disagree about the size of the effect, not about the direction.
Peptide content and chromatographic purity are separate determinations and a certificate that reports only one has answered only one question. Content is the one that tells you how much is in the vial.
Written in the hope of being told what I have missed.
Narrowing post #62, because the general version has more than one answer.
On field-by-field walk through a certificate, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting bit.
If you can post the two or three numbers you are working from, several people here will check the arithmetic rather than argue about the conclusion.
The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested every lot for this" and "we established this once".
This follows post #62 rather than contradicting it.
I think the field-by-field walk through a certificate question is answerable and has not been answered, which is a more optimistic position than most of this thread.
An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main peak and nothing about what it is.
I came in to disagree and I am leaving without a disagreement.
Picking up post #66: that is the part I would want checked first.
Source for the field-by-field walk through a certificate figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the paper is.
Reading the surrounding paragraph is worth the two minutes. The authors are more careful than their summarisers.
A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to reproduce it.
Where I part company with post #67, and it is a narrow parting.
When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient over 20 minutes". The second lets someone reproduce the analysis. The first does not.
Worth reading the earlier posts in this thread before acting on mine.
A certificate is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is not nothing.
That is one dataset and I would not build a rule on it.
Grateful for the specificity. Vague answers to this question are what sent me looking.
Filing a mild objection to the consensus on field-by-field walk through a certificate. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
Post #71 put the caveat in the right place and I want to underline it.
Field-by-field walk through a certificate was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Building on post #75 rather than restating it.
A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is not nothing. What makes it usable: lot identifier matching the container, test date, method identification specific enough to reproduce, the actual result as a number, and the acceptance criterion stated separately from the result.
That is the version I use. It may not be the version that is correct.
A definition problem is doing most of the work in this field-by-field walk through a certificate discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is small.
Practical experience of field-by-field walk through a certificate, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.
Taking post #79 at face value and following it one step further.
Adding a small correction to the field-by-field walk through a certificate summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
Sensible. I would want the same detail before I acted on it either.
Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If endotoxin matters, it needs to be tested and reported.
This has been discussed before and I could not find the thread, so, again.
On field-by-field walk through a certificate, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Answering the question post #82 raises rather than the one it answers.
Asking for the batch record rather than the certificate is a reasonable request and the response to it is informative whichever way it goes.
That is the practical version. The rigorous version is longer and says the same thing.
Peptide content and chromatographic purity are separate determinations and a certificate that reports only one has answered only one question. Content is the one that tells you how much is in the vial.
What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the acceptance limit stated separately. A certificate missing any of these is weaker.
Clear enough that I do not think I have a follow-up, which is unusual.